Laurie Toich, Assistant Editor

The National Institutes of Health presented grants to 88 innovative biomedical researchers.

Despite widespread criticism, the United States may be paying less for hepatitis c virus drugs than other developed countries.

Patients with memory dysfunctions or depression may be less likely maintain adherence to oral oncoltyics.

An award of $347 million has been given to 16 organizations involved with the Hospital Improvement and Innovation Network.

New Jersey explores new initiatives to combat opioid addiction.

Merck launches Biosimilars Clarified to illustrate potential of cost-saving biologic drugs.

New research may have discovered why anti-amyloid beta immunotherapy fails in many patients.

The new rule provides safeguards and protections for Medicare and Medicaid beneficiaries.

Information about the beta-barrel assembly machinery complex could lead to new treatments for drug-resistant bacteria.

Top news of the day from across the healthcare landscape.

Findings from clinical trials of dabrafenib suggest that combining it with an MEK inhibitor will benefit pediatric patients with gliomas.

Approximately 56% of patients age 90 and older with Alzheimer’s disease used psychotropic drugs.

Increasing efforts are being made to provide health for Flint residents affected by the water crisis.

Top news of the day from across the healthcare landscape.

Findings from the KEYNOTE-024 clinical trial will be presented at the European Society of Medical Oncology.

The FDA accepted the supplemental Biologics License Application for Lucentis.

Top news of the day from across the healthcare landscape.

Novartis presented results from clinical trials of Zykadia at the European Society of Medical Oncology Congress.

The FDA approved Carnexiv as a short-term replacement for oral carbamazepine.

A survey from Novartis revealed that 57% of patients with psoriasis did not achieve clear or almost clear skin.

Adjuvant treatment with recombinant, human monoclonal antibody extended overall survival in patients with melanoma in a recent trial.

Adjuvant treatment with Yervoy increased overall survival in patients with melanoma.

A 37% increase in opioid use disorder was found from 2002 to 2014.

Top news of the day from across the healthcare landscape.

LEE011 plus letrozole may prove to be effective first-line breast cancer therapy.

The Centers for Medicare and Medicaid Services have created a campaign to decrease the uninsured rate of young adults.

LEE011 plus letrozole demonstrates significant progression free survival in patients with breast cancer.

The caffeine-based compounds could prevent the misfolding of α-synuclein.

Researchers discover which type of gut bacteria may influence the effectiveness of chemotherapy.

Researchers discover which type of gut bacteria may influence the effectiveness of chemotherapy.